The results from our limited analysis of breast cancer tissues, including one from a patient with the M1775R mutation, are in line with our in vitro findings and the notion that RAD51 and RPA foci levels are elevated in cells that express M1775R. This evidence concerns the gene RAD51 and breast cancer.